Please assess the completion status of the following clinical trial:

Trial Title: Effects of an Amino Acid Mixture on Gastrointestinal Function, Inflammation and Fluid Balance: A Pilot Study in Patients With Inflammatory Bowel Disease

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: TRIPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Colectomy with ileostomy~   a. Ileostomy alone with less than 30 cm of small bowel resected i. A diverting ileostomy is permitted~2. Stable disease activity with no or mild inflammation felt not to significantly impact gastrointestinal (GI) output.~3. Any of the following:~   1. Need for IV fluids \>2x/month~  2. Intake of \> 1.5 liters of oral fluid daily~4. GI output of \> 1.3 liters in a 24-hour period for three days each week during a 14 day screening period (does not need to be consecutive days)~5. Stable doses of anti-diarrheal agents, octreotide or Gattex~6. Stable doses of anti-inflammatory agents and/or antibiotics~7. Willing to comply with study visits and assessments, including product intake.~Exclusion:~1. Chronic renal insufficiency glomerular filtration rate (GFR) \< 40~2. Significant chronic liver disease altering fluid balance~3. Uncontrolled flare of inflammatory disease~   a. (Inflammation can be present but at a stable at least partly controlled level) b. An anticipated change in medication in the next 3 months i. May be included 8 weeks after changing medications if they are stable c. Anticipated gastrointestinal surgery in the subsequent 3 months i. May be included if they are 4 months out from surgery and stable~4. Diabetes~5. Use of Lactulose/Mannitol solution is contraindicated~6. Current Diagnosis of Cancer~   a. May be included if they are 4 or more months out from cancer therapy (i.e. chemotherapy, etc.)~7. Aversion to the taste of enterade® or inability to take the product as instructed

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- amino acid mixture beverage (Type: EXPERIMENTAL): amino acid based hydration beverage. It will be given 8 oz, twice daily for the first 4 weeks of randomized blinded intervention. It will be given in same dose during 4 week open label intervention.
- glucose based sports drink (Type: ACTIVE_COMPARATOR): glucose based hydration beverage. It will be given 8oz, twice daily for the first 4 weeks of randomized blinded intervention.

Based on this trial design, predict the completion outcome and termination type (if applicable).